fluorescein-5-isothiocyanate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, CC; Liu, XD; Song, CY; Tian, X | 1 |
| Song, N; Zhao, J; Zhao, L; Zhu, M | 1 |
| Chen, D; Chu, BB; Cong, Y; Hong, H; Lu, W; Mazar, AP; Ross, BD; Van Dort, ME; Wang, Y; Yang, D; Yang, G | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway.
Topics: Antioxidants; Apoptosis; Bufanolides; Caspase 3; Cell Line; Cell Line, Tumor; Cysteine; Docetaxel; Doxorubicin; Fluorescein-5-isothiocyanate; Humans; Necroptosis; Propidium; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha | 2022 |
Topics: Animals; Biocompatible Materials; Carcinoma; Cell Line, Tumor; Drug Stability; Female; Fluorescein-5-isothiocyanate; Lymphatic Metastasis; Mammary Neoplasms, Animal; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; Peptides, Cyclic; Radiopharmaceuticals; Random Allocation; Technetium; Tomography, Emission-Computed, Single-Photon; Triple Negative Breast Neoplasms | 2019 |
Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative Breast Cancer by Positron Emission Tomography.
Topics: Animals; Antibodies, Monoclonal; Female; Fluorescein-5-isothiocyanate; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Mice; Positron-Emission Tomography; Protein Engineering; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |